Updated Hepatic Encephalopathy Guidelines Have Been Issued

New standards emphasize social support and early medication use for patients navigating this liver-related condition.

Updated on Oct. 10, 2026 in Alzheimer’s

Isometric editorial illustration of a sterile medical infusion stand in a minimalist clinical room, representing updated liver condition management guidelines. — The American College of Gastroenterology has issued updated clinical guidelines for managing hepatic encephalopathy, emphasizing earlier medication use and social support systems. AI Illustration. Upload story photo >

Live Poll

Do you trust that new medical guidelines prioritize the needs of patients and their caregivers?

The American College of Gastroenterology released updated clinical guidelines for managing hepatic encephalopathy. These standards highlight the role of social infrastructure in care and recommend earlier initiation of rifaximin alongside lactulose for hospitalized patients.

Why it matters

The guidelines aim to lower hospital readmission rates by prioritizing the prevention of recurrent symptoms. They also address the shift in common triggers, noting that acute kidney injury and infections now occur more frequently than gastrointestinal bleeding.

These guidelines are based on clinical consensus regarding the management of hepatic encephalopathy. Data indicates 80% of patients improve following a lactulose trial, though 10% to 15% will fail, a finding that informs when clinicians should consider alternative diagnostic pathways.

The players

American College of Gastroenterology

A professional medical society that establishes evidence-based clinical standards for digestive health and liver disease management.

The details

Clinicians are now instructed to titrate lactulose dosing according to the Bristol stool scale to ensure efficacy. The guidelines also formally introduce social infrastructure as a fifth axis of care, acknowledging that environmental factors significantly influence patient outcomes. For those with grade 3 or higher encephalopathy, inpatient teams are advised to use monitored settings or ICU transfers to manage safety.

October 9, 2026: The American College of Gastroenterology published the guideline summary.
8 weeks: The recommended timeframe for re-assessing patients after they begin a lactulose regimen.

Health Landscape

These guidelines modernize the approach to hepatic encephalopathy by moving beyond reactive blood ammonia testing toward a holistic, patient-centered model. This update aligns clinical practice with the broader medical shift toward managing chronic liver complications through integrated social and pharmacological support.

If you or a loved one are managing hepatic encephalopathy, consider discussing the new focus on social support with your care team to identify potential triggers or barriers to treatment adherence. You should specifically ask your doctor if a review of current lactulose dosing protocols is warranted under these updated standards.

The takeaway

The new guidelines stress that a diagnosis of hepatic encephalopathy remains clinical, meaning it relies heavily on observations from patients and their caregivers. Families are encouraged to engage in detailed conversations with their medical team, as education can take 10 to 15 minutes to ensure effective symptom monitoring.